IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

(Investigative Ophthalmology and Visual Science. 2006;47:2336-2340.)
© 2006 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.05-1456
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (19)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schaumberg, D. A.
Right arrow Articles by Zee, R. Y. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schaumberg, D. A.
Right arrow Articles by Zee, R. Y. L.

A Prospective Assessment of the Y402H Variant in Complement Factor H, Genetic Variants in C-Reactive Protein, and Risk of Age-Related Macular Degeneration

Debra A. Schaumberg,1,2 William G. Christen,1 Piotr Kozlowski,3 David T. Miller,3,4 Paul M. Ridker,1,5 and Robert Y. L. Zee1,5

From the Divisions of 1Preventive Medicine and 3Hematology and the 5Center for Cardiovascular Disease Prevention, Brigham and Women’s Hospital, Boston, Massachusetts; the 2Department of Ophthalmology, Schepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts; and the 4Division of Genetics, Children’s Hospital, Boston, Massachusetts.

PURPOSE. Two biologically related factors, complement factor H (CFH) and C-reactive protein (CRP), have been associated with AMD. The Y402H variant of CFH is located within the binding site of CFH for CRP. Although plasma CRP levels have been related to AMD and plasma CRP levels are partly determined by genetic variation, there is no information on whether genetic variants in CRP are associated with AMD.

METHODS. A prospective analysis was performed of 111 men who eventually developed AMD and 401 men who remained free of AMD, all participants in the Physicians’ Health Study. Genotypes were determined for the common T->C single nucleotide polymorphism (SNP) in exon 9 of CFH (rs1061170; protein Y402H), as well as seven previously described CRP SNPs (rs3093059, rs2794521, rs3091244, rs1417938, rs1800947, rs1130864, and rs1205). Logistic regression analysis was used to evaluate individual SNPs, as well as six CRP haplotypes for association with AMD.

RESULTS. The high-risk C allele of CFH was present in 45% of cases and 34% of controls. An odds ratio (OR) of 1.46 was observed for AMD (95% confidence interval [CI]: 1.05–2.04) for TC heterozygotes and an OR of 2.13 (95% CI: 1.10–4.16) for CC homozygotes, assuming a multiplicative (log-additive) model and attributable fraction of 25% (95% CI: 1% to 44%) was calculated. For CRP, single-marker or haplotype-based analysis failed to reveal any significant associations with a risk of AMD.

CONCLUSIONS. These prospective data confirmed an association between the Y402H variant of CFH and a risk of AMD. In contrast, although a biologically plausible, genetic variation in CRP does not appear to be associated with a risk of AMD. Further prospective studies of a larger number of subjects are needed to substantiate available information on the genetic epidemiology of AMD.




This article has been cited by other articles:


Home page
 IOVSHome page
Y.-Y. Tsai, J.-M. Lin, L. Wan, H.-J. Lin, Y. Tsai, C.-C. Lee, C.-H. Tsai, F.-J. Tsai, and S.-H. Tseng
Interleukin Gene Polymorphisms in Age-Related Macular Degeneration
Invest. Ophthalmol. Vis. Sci., February 1, 2008; 49(2): 693 - 698.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
A. Swaroop, K. E. Branham, W. Chen, and G. Abecasis
Genetic susceptibility to age-related macular degeneration: a paradigm for dissecting complex disease traits
Hum. Mol. Genet., October 15, 2007; 16(R2): R174 - R182.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
C. L. Thompson, B. E.K. Klein, R. Klein, Z. Xu, J. Capriotti, T. Joshi, D. Leontiev, K. E. Lee, R. C. Elston, and S. K. Iyengar
Complement factor H and hemicentin-1 in age-related macular degeneration and renal phenotypes
Hum. Mol. Genet., September 1, 2007; 16(17): 2135 - 2148.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
M. M. Jones, N. Manwaring, J. J. Wang, E. Rochtchina, P. Mitchell, and C. M. Sue
Mitochondrial DNA Haplogroups and Age-Related Maculopathy
Arch Ophthalmol, September 1, 2007; 125(9): 1235 - 1240.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
D. A. Schaumberg, W. G. Christen, J. E. Buring, R. J. Glynn, N. Rifai, and P. M. Ridker
High-Sensitivity C-Reactive Protein, Other Markers of Inflammation, and the Incidence of Macular Degeneration in Women
Arch Ophthalmol, March 1, 2007; 125(3): 300 - 305.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
M. B. Gorin
A Clinician's View of the Molecular Genetics of Age-Related Maculopathy
Arch Ophthalmol, January 1, 2007; 125(1): 21 - 29.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
P. T. Johnson, K. E. Betts, M. J. Radeke, G. S. Hageman, D. H. Anderson, and L. V. Johnson
Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid
PNAS, November 14, 2006; 103(46): 17456 - 17461.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Association for Research in Vision and Ophthalmology